Considering the pivotal role of G6PD, the rate-limiting enzyme of PPP, in glucose flux redirection and cancer cell proliferation, we then assessed its activity in Pol ι differentially expressed ESCC cell lines. The gene discussed is G6PD; the disease is esophageal squamous cell carcinoma.